FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:324-325 January 28, 1999 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Howard E. Gendelman, Stuart A. Lipton, Leon Epstein, and Susan Swindells. 615 pp., illustrated. New York, Chapman & Hall, 1998. $169.95. ISBN 0-412-08631-X.

Worldwide, 33 million adults and 2 million children are infected with human immunodeficiency virus type 1 (HIV-1). Despite preventive efforts, the epidemic of the acquired immunodeficiency syndrome (AIDS) continues to spread rapidly. Every day 16,000 persons become infected with the virus. Most of them live in developing countries, where costly antiretroviral medications are not available. It is estimated that in 30 to 50 percent of HIV-1–infected people, neurologic complications will develop. This virus can affect virtually every aspect of the central and peripheral nervous systems, directly or indirectly. The socioeconomic consequences of the neurologic dysfunction caused by HIV-1 infection are . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.